The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ARQT FINANCIAL STATEMENTS

Arcutis Biotherapeutics Inc — balance sheet, income statement and cash flow trends

ARQTArcutis Biotherapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-250 M0250 M500 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue464 M $Gross Profit422.9 M $ · 91%Operating Income34.3 M $ · 7%Pre-tax Income29.3 M $ · 6%Net Income to Owners28.5 M $ · 6%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue464 M $+76.1%
Gross Profit422.9 M $+80.2%
Operating Income34.3 M $—
EBITDA44.1 M $—
Net Income to Owners28.5 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets488.5 M
  • Equity220.6 M $45%
  • Current Liabilities160.3 M $33%
  • Long-term Liabilities107.6 M $22%

Key Figures

YoY change
Total Assets488.5 M $+38.6%
Total Liabilities268 M $+25.5%
Total Equity220.6 M $+58.7%
Cash & ST Investments238.6 M $+24.8%
Total Debt114.1 M $+3.6%
Net Debt80 M $+115.6%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-300 M-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-50 M-25 M025 M39.3 M $Operating-86 M $Investing8.3 M $Financing-38.4 M $Net Change

Key Figures

YoY change
Operating Cash Flow39.3 M $—
Capital Expenditures158 K $-97.3%
Free Cash Flow39.2 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ARQT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.